PTC Therapeutics, Inc.
PTCT
$50.47
-$0.098-0.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.61% | 1,046.28% | 57.71% | 19.79% | 50.13% |
| Total Depreciation and Amortization | 8.05% | -86.96% | -91.62% | -89.55% | -86.24% |
| Total Amortization of Deferred Charges | 2.37% | 1.01% | 2.68% | -47.64% | -47.60% |
| Total Other Non-Cash Items | -51.41% | -7.38% | -113.60% | -73.00% | -68.66% |
| Change in Net Operating Assets | -49.58% | -164.24% | 144.28% | 30.99% | -134.51% |
| Cash from Operations | 18.36% | 1,129.64% | 70.08% | -430.28% | -406.04% |
| Capital Expenditure | -117.86% | 82.02% | 32.32% | 91.79% | 218.09% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -315.15% | -73.44% | 405.54% | -81.47% | -478.83% |
| Cash from Investing | -540.15% | -60.41% | 383.54% | -44.19% | -177.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -15.54% | 675.91% | 994.75% | -83.37% | -74.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -100.00% | -21,311.76% | 1,612,046.67% |
| Cash from Financing | -98.39% | 1,642.59% | -95.73% | -624.46% | 1,235.22% |
| Foreign Exchange rate Adjustments | 361.96% | 365.67% | -379.58% | 466.30% | -150.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -545.34% | 1,634.23% | -40.42% | -198.83% | 1,242.22% |